Ravi A Madan, Clinical researcher at the National Cancer Institute, shared an article by Susan F. Slovin, et al. on X:
“Dr. Susan Slovin Memorial Sloan Kettering Cancer Center asks some key questions regarding Prostate Cancer.
Immune Checkpoint Combos in mCRPC: Where Are We Going, What Are We Doing, and Why?”
Immune Checkpoint Combos in Metastatic Castration-Resistant Prostate Cancer: Where Are We Going, What Are We Doing, and Why?
Authors: Susan F. Slovin, et al.
